Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
Thrower SL, James L, Hall W, Green KM, Arif S, Allen JS, Van-Krinks C, Lozanoska-Ochser B, Marquesini L, Brown S, Wong FS, Dayan CM, Peakman M.
Thrower SL, et al. Among authors: peakman m.
Clin Exp Immunol. 2009 Feb;155(2):156-65. doi: 10.1111/j.1365-2249.2008.03814.x. Epub 2008 Nov 20.
Clin Exp Immunol. 2009.
PMID: 19040615
Free PMC article.
Clinical Trial.